US Stock MarketDetailed Quotes

NAVB Navidea Biopharmaceuticals

Watchlist

0.000
0.0000.00%

15min DelayClose Dec 20 16:00 ET

10.01KMarket Cap0.00P/E (TTM)

Navidea Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-451.60%-10.25M

319.25%4.69M

32.63%-1.72M

12.05%-8.99M

10.82%-2.43M

7.67%-1.86M

11.41%-2.14M

16.54%-2.56M

-25.01%-10.22M

-6.71%-2.73M

Net income from continuing operations

-69.60%-9.68M

301.10%6.03M

50.58%-1.48M

-29.38%-15.18M

4.64%-3.48M

-134.13%-5.71M

-12.17%-3M

-0.69%-2.99M

-9.41%-11.73M

-29.37%-3.65M

Operating gains losses

---750K

----

124.35%65.08K

----

-4,827.04%-267.27K

1,076.39%78.77K

Depreciation and amortization

9.41%27.03K

24.63%27.13K

20.44%27.56K

24.51%95.82K

24.36%26.47K

36.74%24.7K

9.63%21.77K

28.90%22.88K

9.32%76.95K

12.65%21.28K

Other non cash items

56.02%179.07K

7.31%115.7K

-832.87%-1.07M

114.43%610.39K

171.72%241.45K

97.89%114.78K

252.60%107.82K

36.48%146.34K

-29.14%284.66K

194.39%88.86K

Change In working capital

-101.00%-35.06K

-337.02%-1.64M

911.32%779.46K

440.34%5.12M

31.35%834.35K

1,489.27%3.52M

935.87%690K

219.96%77.07K

-48.51%947.17K

446.09%635.2K

-Change in receivables

111.06%13.84K

-115.94%-13.67K

-33.09%-30.41K

401.10%92.36K

908.22%154.56K

-248.58%-125.12K

178.84%85.78K

-6.72%-22.85K

-103.66%-30.68K

-73.52%15.33K

-Change in inventory

--0

-101.50%-110

80.63%-33.29K

-2,563.10%-459.2K

-1,120.66%-283.54K

-10,511.43%-11.14K

158.17%7.32K

-4,932.31%-171.84K

110.98%18.64K

116.36%27.78K

-Change in prepaid assets

-61.53%208.62K

85.89%316.85K

-55.13%108.05K

165.73%951.86K

98.85%-1.71K

245.96%542.28K

-22.70%170.45K

85.30%240.83K

-64.86%358.2K

-1,596.13%-149.02K

-Change in payables and accrued expense

-110.12%-248.65K

-425.64%-1.93M

13,710.81%744.1K

358.95%4.05M

25.24%1.01M

2,645.66%2.46M

2,377.85%592.46K

83.79%-5.47K

121.66%882.34K

177.51%802.67K

-Change in other current liabilities

90.30%-8.87K

89.62%-9.24K

89.61%-8.99K

6.52%-275.72K

89.65%-8.75K

-69.95%-91.44K

-12.08%-88.97K

-12.05%-86.57K

-13.21%-294.95K

-12.40%-84.52K

-Change in other working capital

----

5,478.89%759.18K

-237.04%-31.47K

1,447.07%744.72K

-435.46%-77.04K

435.46%122.96K

-0.01%13.61K

0.00%22.96K

Cash from discontinued investing activities

Operating cash flow

-451.60%-10.25M

319.25%4.69M

32.63%-1.72M

12.05%-8.99M

10.82%-2.43M

7.67%-1.86M

11.41%-2.14M

16.54%-2.56M

-25.01%-10.22M

-6.71%-2.73M

Investing cash flow

Cash flow from continuing investing activities

1,029.32%733.48K

46.37%-65K

66.66%-39.41K

-18.49%-390.35K

19.45%-72.04K

40.75%-78.93K

-208.36%-121.19K

-75.17%-118.19K

20.20%-329.42K

-8.31%-89.44K

Net PPE purchase and sale

--0

105.06%336

64.14%-15.07K

-150.16%-63.09K

--0

20.03%-14.43K

-145.29%-6.64K

---42.02K

81.30%-25.22K

32.95%-4.47K

Net intangibles purchase and sale

74.38%-16.52K

42.96%-65.34K

68.05%-24.34K

-7.58%-327.26K

15.22%-72.04K

44.00%-64.5K

-213.03%-114.55K

-12.90%-76.18K

-9.43%-304.21K

-11.93%-84.97K

Cash from discontinued investing activities

Investing cash flow

-564.75%-524.66K

46.37%-65K

66.66%-39.41K

-18.49%-390.35K

19.45%-72.04K

40.75%-78.93K

-208.36%-121.19K

-75.17%-118.19K

20.20%-329.42K

-8.31%-89.44K

Financing cash flow

Cash flow from continuing financing activities

-103.04%-188.57K

8.26%1.48M

40.92%-200.54K

-41.01%7.14M

21.74%-99.76K

181.28%6.21M

-33.46%1.37M

-104.26%-339.45K

18.59%12.11M

-108.03%-127.48K

Net issuance payments of debt

-113.86%-138.57K

-114.75%-204.5K

40.92%-200.54K

503.01%1.98M

42.44%-64.66K

--1M

827.38%1.39M

-79.71%-339.45K

-19,162.63%-491.78K

-79.45%-112.33K

Net common stock issuance

--0

----

-99.31%30

-98.64%30

--0

----

-99.90%4.35K

-91.16%2.21K

Net preferred stock issuance

--0

----

-51.33%6.17M

--0

179.61%6.17M

----

112.26%12.68M

--0

Net other financing activities

94.81%-50K

----

-1,060.11%-1.01M

-102.36%-35.13K

---963.27K

----

57.41%-87.32K

-5,325.00%-17.36K

Cash from discontinued financing activities

Financing cash flow

-103.04%-188.57K

8.26%1.48M

40.92%-200.54K

-41.01%7.14M

21.74%-99.76K

181.28%6.21M

-33.46%1.37M

-104.26%-339.45K

18.59%12.11M

-108.03%-127.48K

Net cash flow

Beginning cash position

1,773.06%6.14M

-97.22%33.8K

-52.83%2M

58.43%4.23M

-35.89%4.6M

-95.39%328.01K

-83.79%1.22M

58.43%4.23M

155.02%2.67M

92.76%7.18M

Current changes in cash

-153.34%-2.28M

787.22%6.11M

34.90%-1.96M

-243.24%-2.24M

11.56%-2.6M

6,779.60%4.27M

-126.11%-889.1K

-162.31%-3.01M

-3.88%1.56M

-179.88%-2.95M

End cash Position

-16.00%3.86M

1,773.06%6.14M

-97.22%33.8K

-52.83%2M

-35.89%4.6M

-95.39%328.01K

-83.79%1.22M

58.43%4.23M

Free cash flow

-429.98%-10.27M

304.61%4.63M

34.13%-1.76M

11.10%-9.38M

11.10%-2.51M

9.72%-1.94M

7.89%-2.26M

14.56%-2.67M

-22.82%-10.55M

-6.76%-2.82M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-451.60%-10.25M	319.25%4.69M	32.63%-1.72M	12.05%-8.99M	10.82%-2.43M	7.67%-1.86M	11.41%-2.14M	16.54%-2.56M	-25.01%-10.22M	-6.71%-2.73M
Net income from continuing operations	-69.60%-9.68M	301.10%6.03M	50.58%-1.48M	-29.38%-15.18M	4.64%-3.48M	-134.13%-5.71M	-12.17%-3M	-0.69%-2.99M	-9.41%-11.73M	-29.37%-3.65M
Operating gains losses	---750K	----	----	124.35%65.08K	----	----	----	----	-4,827.04%-267.27K	1,076.39%78.77K
Depreciation and amortization	9.41%27.03K	24.63%27.13K	20.44%27.56K	24.51%95.82K	24.36%26.47K	36.74%24.7K	9.63%21.77K	28.90%22.88K	9.32%76.95K	12.65%21.28K
Other non cash items	56.02%179.07K	7.31%115.7K	-832.87%-1.07M	114.43%610.39K	171.72%241.45K	97.89%114.78K	252.60%107.82K	36.48%146.34K	-29.14%284.66K	194.39%88.86K
Change In working capital	-101.00%-35.06K	-337.02%-1.64M	911.32%779.46K	440.34%5.12M	31.35%834.35K	1,489.27%3.52M	935.87%690K	219.96%77.07K	-48.51%947.17K	446.09%635.2K
-Change in receivables	111.06%13.84K	-115.94%-13.67K	-33.09%-30.41K	401.10%92.36K	908.22%154.56K	-248.58%-125.12K	178.84%85.78K	-6.72%-22.85K	-103.66%-30.68K	-73.52%15.33K
-Change in inventory	--0	-101.50%-110	80.63%-33.29K	-2,563.10%-459.2K	-1,120.66%-283.54K	-10,511.43%-11.14K	158.17%7.32K	-4,932.31%-171.84K	110.98%18.64K	116.36%27.78K
-Change in prepaid assets	-61.53%208.62K	85.89%316.85K	-55.13%108.05K	165.73%951.86K	98.85%-1.71K	245.96%542.28K	-22.70%170.45K	85.30%240.83K	-64.86%358.2K	-1,596.13%-149.02K
-Change in payables and accrued expense	-110.12%-248.65K	-425.64%-1.93M	13,710.81%744.1K	358.95%4.05M	25.24%1.01M	2,645.66%2.46M	2,377.85%592.46K	83.79%-5.47K	121.66%882.34K	177.51%802.67K
-Change in other current liabilities	90.30%-8.87K	89.62%-9.24K	89.61%-8.99K	6.52%-275.72K	89.65%-8.75K	-69.95%-91.44K	-12.08%-88.97K	-12.05%-86.57K	-13.21%-294.95K	-12.40%-84.52K
-Change in other working capital	----	----	----	5,478.89%759.18K	-237.04%-31.47K	1,447.07%744.72K	-435.46%-77.04K	435.46%122.96K	-0.01%13.61K	0.00%22.96K
Cash from discontinued investing activities
Operating cash flow	-451.60%-10.25M	319.25%4.69M	32.63%-1.72M	12.05%-8.99M	10.82%-2.43M	7.67%-1.86M	11.41%-2.14M	16.54%-2.56M	-25.01%-10.22M	-6.71%-2.73M
Investing cash flow
Cash flow from continuing investing activities	1,029.32%733.48K	46.37%-65K	66.66%-39.41K	-18.49%-390.35K	19.45%-72.04K	40.75%-78.93K	-208.36%-121.19K	-75.17%-118.19K	20.20%-329.42K	-8.31%-89.44K
Net PPE purchase and sale	--0	105.06%336	64.14%-15.07K	-150.16%-63.09K	--0	20.03%-14.43K	-145.29%-6.64K	---42.02K	81.30%-25.22K	32.95%-4.47K
Net intangibles purchase and sale	74.38%-16.52K	42.96%-65.34K	68.05%-24.34K	-7.58%-327.26K	15.22%-72.04K	44.00%-64.5K	-213.03%-114.55K	-12.90%-76.18K	-9.43%-304.21K	-11.93%-84.97K
Cash from discontinued investing activities
Investing cash flow	-564.75%-524.66K	46.37%-65K	66.66%-39.41K	-18.49%-390.35K	19.45%-72.04K	40.75%-78.93K	-208.36%-121.19K	-75.17%-118.19K	20.20%-329.42K	-8.31%-89.44K
Financing cash flow
Cash flow from continuing financing activities	-103.04%-188.57K	8.26%1.48M	40.92%-200.54K	-41.01%7.14M	21.74%-99.76K	181.28%6.21M	-33.46%1.37M	-104.26%-339.45K	18.59%12.11M	-108.03%-127.48K
Net issuance payments of debt	-113.86%-138.57K	-114.75%-204.5K	40.92%-200.54K	503.01%1.98M	42.44%-64.66K	--1M	827.38%1.39M	-79.71%-339.45K	-19,162.63%-491.78K	-79.45%-112.33K
Net common stock issuance	--0	----	----	-99.31%30	-98.64%30	--0	----	----	-99.90%4.35K	-91.16%2.21K
Net preferred stock issuance	--0	----	----	-51.33%6.17M	--0	179.61%6.17M	----	----	112.26%12.68M	--0
Net other financing activities	94.81%-50K	----	----	-1,060.11%-1.01M	-102.36%-35.13K	---963.27K	----	----	57.41%-87.32K	-5,325.00%-17.36K
Cash from discontinued financing activities
Financing cash flow	-103.04%-188.57K	8.26%1.48M	40.92%-200.54K	-41.01%7.14M	21.74%-99.76K	181.28%6.21M	-33.46%1.37M	-104.26%-339.45K	18.59%12.11M	-108.03%-127.48K
Net cash flow
Beginning cash position	1,773.06%6.14M	-97.22%33.8K	-52.83%2M	58.43%4.23M	-35.89%4.6M	-95.39%328.01K	-83.79%1.22M	58.43%4.23M	155.02%2.67M	92.76%7.18M
Current changes in cash	-153.34%-2.28M	787.22%6.11M	34.90%-1.96M	-243.24%-2.24M	11.56%-2.6M	6,779.60%4.27M	-126.11%-889.1K	-162.31%-3.01M	-3.88%1.56M	-179.88%-2.95M
End cash Position	-16.00%3.86M	1,773.06%6.14M	-97.22%33.8K	-52.83%2M	-52.83%2M	-35.89%4.6M	-95.39%328.01K	-83.79%1.22M	58.43%4.23M	58.43%4.23M
Free cash flow	-429.98%-10.27M	304.61%4.63M	34.13%-1.76M	11.10%-9.38M	11.10%-2.51M	9.72%-1.94M	7.89%-2.26M	14.56%-2.67M	-22.82%-10.55M	-6.76%-2.82M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data